Tests for urogenital infections
Tests for urogenital infections
We perform laboratory diagnostics for urogenital infections and microbiocenosis disorders in both women and men. Separate tests and ready-made panels are available for screening and diagnosis clarification.
Available tests include:
- Smear microscopy: purity level, increased leukocytes, decreased lactobacilli, presence of aerobic, intestinal bacteria, fungi, protozoa, etc.
- Bacterial culture of vaginal/urethral discharge (gram-positive and gram-negative), determination of antibiotic sensitivity.
- PCR tests:
- UNIFLOR SCREEN
- Neisseria gonorrhoeae (gonorrhea);
- Chlamydia trachomatis (urogenital chlamydia);
- Trichomonas vaginalis (trichomoniasis);
- Mycoplasma genitalium (genital mycoplasmosis).
- Opportunistic bacteria and fungi that may indicate dysbiotic changes and cause infectious-inflammatory diseases of the genital organs:
- Gardnerella vaginalis (anaerobic vaginitis, bacterial vaginosis);
- Candida albicans (candidiasis);
- Mycoplasma hominis (mycoplasmosis);
- Ureaplasma urealyticum (ureaplasmosis);
- Ureaplasma parvum (ureaplasmosis).
- HPV PCR test for determining types of human papillomavirus (HPV): high oncogenic (carcinogenic) risk – 16, 18, 26, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 68; low oncogenic risk – 6, 11, 40, 42, 43, 44, 54, 61, 70), DNA (semi-quantitative determination).
Additionally, upon request: screening for syphilis, HIV, hepatitis B and C as part of an extended examination.
Enzyme-linked immunosorbent assay (ELISA), which detects either antibodies (IgG, IgM, IgA) to pathogens or their antigens:
- Chlamydia trachomatis: IgG, IgM, IgA
- Mycoplasma hominis: IgM, IgG
- Ureaplasma urealyticum: IgA, IgG
- Trichomonas vaginalis: IgG, IgM, IgA
- Herpes simplex virus (HSV 1/2): IgG, IgM
- And others.
The final interpretation of results and the need for treatment are determined by a doctor considering symptoms and medical history. Detection of opportunistic microorganisms (e.g., Ureaplasma, M. hominis) without complaints does not always require therapy. Partners are recommended to undergo simultaneous examination/treatment if STIs are detected; abstinence or barrier protection is advised until treatment is completed. Follow-up tests are conducted as prescribed by a doctor within specified timeframes.
Contact us to select the appropriate set of tests and a convenient time for testing. We will help quickly and accurately identify the causes of symptoms and maintain reproductive health.
Available tests include:
- Smear microscopy: purity level, increased leukocytes, decreased lactobacilli, presence of aerobic, intestinal bacteria, fungi, protozoa, etc.
- Bacterial culture of vaginal/urethral discharge (gram-positive and gram-negative), determination of antibiotic sensitivity.
- PCR tests:
- UNIFLOR SCREEN
- Neisseria gonorrhoeae (gonorrhea);
- Chlamydia trachomatis (urogenital chlamydia);
- Trichomonas vaginalis (trichomoniasis);
- Mycoplasma genitalium (genital mycoplasmosis).
- Opportunistic bacteria and fungi that may indicate dysbiotic changes and cause infectious-inflammatory diseases of the genital organs:
- Gardnerella vaginalis (anaerobic vaginitis, bacterial vaginosis);
- Candida albicans (candidiasis);
- Mycoplasma hominis (mycoplasmosis);
- Ureaplasma urealyticum (ureaplasmosis);
- Ureaplasma parvum (ureaplasmosis).
- HPV PCR test for determining types of human papillomavirus (HPV): high oncogenic (carcinogenic) risk – 16, 18, 26, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 68; low oncogenic risk – 6, 11, 40, 42, 43, 44, 54, 61, 70), DNA (semi-quantitative determination).
Additionally, upon request: screening for syphilis, HIV, hepatitis B and C as part of an extended examination.
Enzyme-linked immunosorbent assay (ELISA), which detects either antibodies (IgG, IgM, IgA) to pathogens or their antigens:
- Chlamydia trachomatis: IgG, IgM, IgA
- Mycoplasma hominis: IgM, IgG
- Ureaplasma urealyticum: IgA, IgG
- Trichomonas vaginalis: IgG, IgM, IgA
- Herpes simplex virus (HSV 1/2): IgG, IgM
- And others.
The final interpretation of results and the need for treatment are determined by a doctor considering symptoms and medical history. Detection of opportunistic microorganisms (e.g., Ureaplasma, M. hominis) without complaints does not always require therapy. Partners are recommended to undergo simultaneous examination/treatment if STIs are detected; abstinence or barrier protection is advised until treatment is completed. Follow-up tests are conducted as prescribed by a doctor within specified timeframes.
Contact us to select the appropriate set of tests and a convenient time for testing. We will help quickly and accurately identify the causes of symptoms and maintain reproductive health.
